Long-Lasting Response after Pembrolizumab in a Patient with Metastatic Triple-Negative Breast Cancer

INTRODUCTION: Breast cancer is the first cause of cancer death in women. The triple-negative subtype is associated with aggressive behavior and poor prognosis. Chemotherapy is the main therapeutic option available for these patients, but it is usually associated with short overall survival. CASE PRE...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Breast Care (Basel)
Главные авторы: Peinado, Paloma, Ramírez, Carmen, García-Sáenz, José Angel, Pascual, Alejandro, Fuentes-Antrás, Jesús, Vidal, Natalia, Antoñanzas, Mónica, Moreno, Fernando
Формат: Artigo
Язык:Inglês
Опубликовано: S. Karger GmbH 2020
Предметы:
Novel Insights from Clinical Practice
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7490656/
https://ncbi.nlm.nih.gov/pubmed/32982655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000503849
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы